Literature DB >> 13066723

Investigations on the hypotensive effect of the hydrogenated ergot alkaloids.

H KONZETT, E ROTHLIN.   

Abstract

Entities:  

Keywords:  ERGOT ALKALOIDS/effects; HYPOTENSION/experimental

Mesh:

Substances:

Year:  1953        PMID: 13066723      PMCID: PMC1509327          DOI: 10.1111/j.1476-5381.1953.tb00779.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


× No keyword cloud information.
  4 in total

1.  Peripheral vasomotor effects of adrenaline and noradrenaline acting upon the isolated perfused central nervous system.

Authors:  R D TAYLOR; I H PAGE
Journal:  Circulation       Date:  1951-10       Impact factor: 29.690

2.  Observations on the action of the hydrogenated alkaloids of the ergotoxine group on the circulation in man.

Authors:  H BARCROFT; H KONZETT; H J C SWAN
Journal:  J Physiol       Date:  1951-02       Impact factor: 5.182

3.  Comparative analysis of the effect of hydrogenated ergot alkaloids upon presso- and chemoreceptive reflexes in the cat.

Authors:  G C SUTTON; A CERLETTI; M TAESCHLER
Journal:  Arch Int Pharmacodyn Ther       Date:  1950-12

4.  Augmentation of vasoactive substances by tetraethylammonium chloride.

Authors:  I H PAGE; R D TAYLOR
Journal:  Circulation       Date:  1950-06       Impact factor: 29.690

  4 in total
  7 in total

1.  The action of antisympathomimetic drugs on the urinary excretion of adrenaline and noradrenaline.

Authors:  B G BENFEY; G LEDOUX; M SEGAL
Journal:  Br J Pharmacol Chemother       Date:  1959-09

2.  Studies of the effect of natural and synthetic polypeptide type ergot compounds on a peripheral vascular bed.

Authors:  W H Aellig; B Berde
Journal:  Br J Pharmacol       Date:  1969-07       Impact factor: 8.739

3.  10-Methoxyergoline derivatives as -adrenergic blocking agents.

Authors:  G Arcari; L Bernardi; G Bosisio; S Coda; G B Fregnan; A H Glässer
Journal:  Experientia       Date:  1972-07-15

4.  Effects of phentolamine, dihydroergocristine and isoxsuprine on the blood pressure and heart rate in normotensive, hypotensive and hypertensive rats.

Authors:  C Morpurgo; D Faini; A Falcone
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

5.  Cardiovascular regulation and lipoprotein profile during administration of co-dergocrine in essential hypertension.

Authors:  D E Uehlinger; P Weidmann; M P Gnaedinger
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

6.  VASOCONSTRICTOR ACTION OF TOLAZOLINE.

Authors:  B G BENFEY; D R VARMA
Journal:  Br J Pharmacol Chemother       Date:  1964-02

7.  Cardiovascular regulation during administration of co-dergocrine to normal subjects.

Authors:  A Gerber; P Weidmann; K Laederach
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.